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Abstract  
Background: High demand on healthcare services and the growing capability of artificial 
intelligence has led to the development of conversational agents designed to support a variety of 
health-related activities - including behaviour change, treatment support, health monitoring, 
training, triage, and screening support. Automation of these tasks could free clinicians to focus 
on more complex work and increase accessibility to healthcare services for the general public. 
An overarching assessment of the acceptability, usability, and effectiveness of these agents in 
healthcare is needed to collate the evidence so that future development can target areas for 
improvement and potential for sustainable adoption.  
Objective: This systematic review aimed to assess the effectiveness and usability of 
conversational agents in healthcare and identify the elements that users like and dislike, to 
inform future research and development of these agents.  
Methods: PubMed, Medline (Ovid), EMBASE, CINAHL, Web of Science, and ACM Digital 
Library were systematically searched for articles published since 2008 that evaluated 
unconstrained natural language processing conversational agents used in healthcare. Endnote 
(version X9; Clarivate Analytics) reference management software was used for initial screening, 
then full-text screening was conducted by one reviewer. Data was extracted and risk of bias was 
assessed by one reviewer and validated by another.  
Results: A total of 31 studies were selected and included a variety of conversational agents - 14 
chatbots (two of which were voice chatbots), 6 embodied conversational agents, 3 each of 
interactive voice response calls, virtual patients, and speech recognition screening systems, as 
well as one contextual question answering agent and one voice recognition triage system. 
Overall, the evidence reported was mostly positive or mixed. Usability and satisfaction 
performed well (27/30 and 26/31) and positive or mixed effectiveness was found in three 
quarters of the studies (23/30), but there were several limitations of the agents highlighted in 
specific qualitative feedback.  
Conclusions: The studies generally reported positive or mixed evidence for the effectiveness, 
usability, and satisfactoriness of the conversational agents investigated, but qualitative user 
perceptions were more mixed. The quality of many of the studies was limited, and improved 
study design and reporting is necessary to more accurately evaluate the usefulness of the agents 
in healthcare and identify key areas for improvement. Further research should also analyse the 
cost-effectiveness, privacy, and security of the agents.  
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Conversational agents are among the many digital technologies being introduced into the 
health sector to address current healthcare challenges, such as shortages of healthcare providers 
reducing the availability and accessibility of healthcare services [1–3]. Conversational agents use 
artificial intelligence - including machine learning (a statistical means of training models with 
data so that they can make predictions based on a variety of features) and natural language 
processing (NLP; the ability to recognize and analyse verbal and written language) - to interact 
with humans, via speech, text, or other input and output on mobile, web-based, or audio-based 
platforms [1,4]. Many of these agents are designed to use NLP so that users can speak or write to 
the agent as they would to a human. The agent can then analyze the input and respond 
appropriately in a conversational manner [5].  
Conversational agents first emerged as a tool in healthcare in 1966, with the development 
of a virtual psychotherapist (ELIZA) that could provide pre-determined answers to text-based 
user input [6]. In the decades since, the capabilities of natural language processing have 
significantly progressed and aided the development of more advanced artificial intelligence 
agents. Many different types of conversational agents that use NLP have been developed - 
including chatbots, embodied conversational agents, and virtual patients - and are accessible by 
telephone, mobile phone, computer, and many other digital platforms [7–10]. The types of input 
that conversational agents can receive and interpret has also expanded, with some conversational 
agents capable of analysing movement - including gestures, facial expressions, and eye 
movements [11,12].  
Conversational agents have been developed for many different aspects of the health 
sector to support healthcare professionals and the general public. Specific uses include screening 
for health conditions, triage, counselling, at-home health management support, and training for 
healthcare professionals [8,13–15]. With phone, mobile, and online platforms widely accessible, 
conversational agents can support populations with limited access to health care or poor health 
literacy [16,17]. They also have the potential to be affordably scaled-up to reach large 
proportions of a population [3] Because of this accessibility, conversational agents are also a 
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promising tool for the advancement of patient-centred care, and can support users’ involvement 
in their own healthcare [17,18]. Personalizable features have the potential to further improve 
usability and satisfaction, though more research is needed to evaluate their effectiveness - in 
achieving their stated health outcomes and reducing costs - and ensure that there are no negative 
consequences for decision-making or privacy [10].  
Despite the large body of research concerning the application of conversational agents to 
healthcare, most reviews have limited their focus to a particular health area, agent type, or 
function [10,19–22]. Though there are a few recent systematic reviews that have examined a 
more comprehensive scope, these have presented an overall synthesis of the body of knowledge. 
One review developed a taxonomy that described the architecture and functions of 
conversational agents in healthcare and the state of the field, but did not evaluate the 
effectiveness, usability, or implications for users [5]. Another systematic review did investigate 
the outcome measures of the studies of conversational agents but limited the inclusion criteria to 
agents that used natural language input and had been tested with human participants [2]. 
Additionally, their initial database searches only retrieved 1531 articles, which raises the concern 
that some relevant articles may have been overlooked [2]. Their search was updated in February 
2018, but given the rapid pace of technological development, there is a need to provide an update 
and expansion to these previous systematic reviews. 
For conversational agents to be successful in healthcare, it is crucial to understand the 
effectiveness of current agents in achieving their intended outcomes. However, it is just as 
important to understand how users feel about and relate to these agents, because the adoption of 
new health technologies depends on users’ perceptions of them (for instance, whether they trust 
the technology, find it easy to use, and feel privacy and data security are being respected) [23]. 
User-identified problems will need to be addressed if conversational agents are to have a 
significant impact in healthcare, because their impact depends on people being willing to use 
them, and preferring to use them over alternatives. The information gathered in this review 
identifies the current issues with conversational agents that need to be overcome and can be used 
to help determine which elements of the agents are most likely to be successful and useful in 
various aspects of healthcare. As conversational agents are often touted as having the potential to 
reduce burdens on healthcare resources, evaluations of the implications of the agents for 
improved healthcare provision and reduced resource demand also need to be assessed.  
Objectives  
The primary objectives of the review are to describe the scope of conversational agents 
currently being used for healthcare activities (by patients, healthcare providers, or the general 
public), examine users’ perceptions of these agents, and evaluate their effectiveness. Three main 
research questions were developed to address these objectives. First, are the conversational 
agents investigated effective at achieving their intended health-related outcomes, and does the 
effectiveness vary depending on the type of agent? Second, how do users rate the usability and 
satisfactoriness of the conversational agents and what specific elements of the agents do they like 
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and dislike? Finally, what are the current limitations and gaps in the utility of conversational 
agents in healthcare? These objectives build on previous systematic reviews while widening the 
scope of included studies to update the body of knowledge on conversational agents in healthcare 
to inform future research and development.   
Methods  
Database Search  
The full methods for this review have been published in detail in a systematic review 
protocol [24]. The Participant, Intervention, Comparison, Outcome (PICO) framework [25] was 
used to develop the search strategy, which was performed following the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) [26]. No study design 
filter was used; any type of study was eligible for inclusion. The search strategy was finalised 
and tailored to the different databases in consultation with a medical librarian. PubMed, Medline 
(Ovid), Embase (Ovid), Cumulative Index of Nursing and Allied Health Literature (CINAHL), 
Web of Science, and ACM Digital Library databases were searched. The search terms were 
grouped into three themes - conversational agents, health application, and outcome assessment - 
to capture all studies that fit the key inclusion criteria: evaluating conversational agents used in 
healthcare.  These themes  were subsequently searched with the structure: conversational agent 
(MeSH OR Keywords) AND health application (MeSH OR Keywords) AND outcome 
assessment (MeSH OR Keywords). The full search strategy can be found in Multimedia 
Appendix A. The search was completed on November 29th, 2019.  
Inclusion and Exclusion Criteria 
 This systematic review aimed to assess conversational agents designed for healthcare 
purposes. Studies that evaluated at least one conversational agent were included. Studies 
targeting any population group, geographical location, and mental or physical health-related 
function (eg. screening, education, training, self-management) were included. These broad 
inclusion criteria were established to enable an assessment of the wide range of applications of 
conversational agents. There was no restriction on study type, as long as the conversational agent 
was evaluated, so intervention and observational studies, such as cross-sectional surveys, cohort 
studies, and qualitative studies, were included. Intervention studies were not required to have a 
specific, or any, comparator.  
During the screening process, studies of conversational agents that were not capable of 
interacting with human users via unconstrained natural language processing (NLP) were 
excluded. These included conversational agents that only allowed users to select from predefined 
options or agents with pre-recorded responses which did not adapt to subsequent user responses. 
The basis of this exclusion is without capability of using NLP computational methods, 
technologies were rudimentary and not advancing the aims of artificial intelligence for 
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autonomous computational agents. As many studies did not explicitly state whether the 
investigated agent was capable of NLP, a description in the paper of the conversational agent 
allowing free text or free speech input was used as an indicator for NLP and these studies were 
included. Studies that did not report the architecture of the agent were excluded.  
Due to the number of conversational agents in development and/or those that do not 
progress to evaluation stages of development, studies which were solely descriptive were 
excluded. Furthermore, due to the pace at which conversational agents have developed over 
recent decades, studies were limited to those published during or after 2008. 2008 was the year 
the first iPhone was released and marks an increase in the prevalence and capabilities of digital 
technology. Only studies published in English were included to ensure accurate interpretation by 
the authors. Conference publications were also excluded to focus the review on peer-reviewed 
literature.  
Outcomes 
The primary objective of this review was to provide an overview of the use of NLP 
conversational agents in healthcare. Therefore, the primary outcomes evaluated were the 
effectiveness of conversational agents in achieving their intended health-related outcomes and 
user perceptions of the agents (including but not limited to acceptability, usability, satisfaction, 
and specific qualitative feedback). Secondary outcomes included improvement in healthcare 
provision and resource implications for the healthcare system.  
Screening and Study Selection  
All studies retrieved from the databases were stored in the reference management 
software Endnote (version X9; Clarivate Analytics), which automatically eliminated duplicates. 
Due to time constraints, the Endnote search function was used to extract relevant studies prior to 
screening of the citations against the inclusion and exclusion criteria by two independent 
reviewers. Where duplicates or publications from the same study were identified, the more recent 
publication or the one with the most detail was selected for inclusion in the review. Any 
disagreements were discussed and if a consensus was not reached a third reviewer was consulted. 
Full Endnote (version X9; Clarivate Analytics) search details can be seen in Multimedia 
Appendix B.  
The full-texts of the articles thought to meet the inclusion criteria were screened by one 
of the reviewers. Fifty-eight of the screened articles deemed eligible for inclusion were 
conference or meeting abstracts, did not have full-texts available, and were excluded. This 
highlights the early developmental stages of many of these agents.   
Data Extraction  
Data was extracted by one reviewer and key data points from the studies that were 
specified in the protocol and identified on further study of the publications were recorded in a 
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spreadsheet and validated by a second reviewer. The data extraction form was based on the 
minimum requirements as recommended by the Cochrane Handbook for Systematic Reviews 
[27]. The types of data extracted from the studies can be seen in Table 1. 
 
Table 1. Data that were extracted from the studies 
Article Information Data Extracted 
General study information  
 Title of publication 
 Year of publication 
 Authors 
Study characteristics  
 Study design 
 Country of study 
 Study population 
 Analysed sample size 
 Comparator(s) 
 Study duration 
Characteristics of the conversational agent(s)  
 Name of conversational agent(s) 
 Architecture 
 Device/platform on which agent is accessed 
 Intended user 
 Primary purpose 
Intended outcome(s) of the conversational 
agent(s) 
 
 Health objective (general) 
 Health outcomes (specific) 
Evaluation  
 Effectiveness in achieving intended purpose 
 Health literacy 
 Improvement in healthcare provision 
 Healthcare resource implications  
 Usability  
 Acceptability / Satisfaction 
 User perceptions qualitative feedback 
 Conclusions  
 Implications for future study 
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Risk of Bias / Quality Assessment  
All quality assessments were conducted by two independent reviewers, with 
disagreements being resolved by consensus. If this was not possible, the opinion of a third 
reviewer was sought. As there was a wide variety of study designs, the study types were 
classified by one reviewer and validated by a second reviewer, with disagreements being 
resolved by discussion with a third reviewer. Because of the broad inclusion criteria that was 
intended to capture all relevant studies, a few of the included studies used implementation 
models for AI research that were beyond the scope of classic public health design methods. This 
resulted in some study designs being categorized as ‘other’. 
The Cochrane Collaboration Risk of Bias tool was used to evaluate the risk of bias in 
randomized controlled trials (RCTs) [28]. The Critical Appraisal Skills Programme tools for 
cohort and qualitative studies were used for the respective studies [29] and the AXIS tool was 
used to assess the quality of cross-sectional survey studies [30]. Studies that were coded as 
‘other’ design types were also assessed using the AXIS tool, which was deemed to be the most 
rigorous and appropriate tool because it systematically evaluates elements of the introduction, 
methods, results, and discussion sections and is not limited to the RCT specific questions used in 
the Risk of Bias tool.  
The results of the Cochrane Collaboration Risk of Bias Tool were summarized using 
RevMan 5.3. Critical Appraisal Skills Programme and AXIS scores were calculated using yes = 
1, no = 0, can’t tell / don’t know = 0 for each question. The scores for each question were 
summed to provide a score for each study, which were averaged according to study type and 
presented in the results.  
Data Analysis and Synthesis 
Due to the variability in populations, interventions, outcomes and study designs, a meta-
analysis of the studies was not possible. Therefore, we report a structured analysis of the findings 
to draw conclusions about the effectiveness and user perceptions of conversational agents in 
healthcare. For the purpose of this review, the agent was considered effective if there was a 
statistically significant (P<.05) improvement in a given outcome as compared to a comparator or 
control, or over time. If no significance was reported or the difference was non-significant or 
significantly worse between groups or over time the agent was considered to have no significant 
evidence supporting it. Limitations and future directions for research were also summarised.  
 The Synthesis Framework for the Assessment of Health Information Technology 
(SF/HIT) was used to structure the evaluation of the studies because it included a whole system 
set of outcome variables [31]. These included effectiveness, satisfaction and perceived ease of 
use / usefulness, among others. According to the framework, evidence for each of the outcome 
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variables was coded as ‘positive or mixed’ or ‘neutral or negative.’ If the study did not address 
the outcome in question, it was coded as ‘neutral or negative’.  
Finally, when qualitative user feedback was reported, it was examined to extract common 
themes by the sections of original text that discussed the qualitative perceptions, reducing them 
to key themes, and then comparing those key themes across the different studies.  
Results 
Included Studies  
Overall, 9441 studies were retrieved from the six databases of which 2782 were 
duplicates. The reference management software Endnote (version X9; Clarivate Analytics) was 
used for initial screening, with keywords based on the original search categories and irrelevant 
studies identified from preliminary viewing used to exclude studies that did not meet the criteria. 
After six passes, 957 citations remained for abstract screening. The primary reasons for 
exclusion at screening stage were that the study did not include an interactive, responsive 
conversational agent (n=470), was a review article (n=65), was not health-related (n=48) or did 
not report any evaluation of the conversational agent (n=46). Of these 957 citations, 293 were 
selected for full-text review. Thirty-one papers were included in the final review. The reasons for 
the exclusion at full-text review are detailed in Figure 1, with the most common being that the 
conversational agent did not use NLP (n=81), no full text was available (n=71), or there was no 
conversational agent in the paper (n=51).  
 
Figure 1. PRISMA flow diagram  
Study Characteristics  
 The characteristics of the 31 included studies are summarized in Multimedia Appendix C. 
Of these studies, 45% (14/31) evaluated conversational agents that had some type of audio or 
speech element. 45% (14/31) of the agents were chatbots (including two voice chatbots and one 
chatbot that also used a wizard), 19% (6/31) were embodied conversational agents (ECA, 
including one virtual doctor), 10% each (3/31) were interactive voice response (IVR) phone 
calls, virtual patients, and speech recognition screening systems, and the final two were a 
contextual question answering agent and a voice recognition triage system. Of the 26 studies that 
reported the device their conversational agent was used on, 35% (9/26) were computers, 27% 
(7/26) were web-based, 23% (6/26) were mobile phone apps, and 15% (4/26) were telephone 
calls, and one study used a tablet (the percentages do not add up to 100% because one agent 
could be used on a computer or telephone).  
 
Figure 2. The number of studies examining agents that were designed for use on certain 
platforms (n = 26, one agent could be used on a computer or telephone) 
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There were a wide variety of areas of healthcare targeted by the conversational agents of 
the included studies. The greatest number (39%, 12/31) addressed mental health issues [13,32–
42], with 19% (6/31) each providing some form of clinical decision or triage support 
[8,12,40,42–44] and treatment support (including encouraging users to get screened) [9,45–49], 
10% (3/31) each were used to support training of healthcare students [15,41,50] and the 
screening or diagnosis of users [14,38,51], 7% (2/31) each targeted physical health [52,53] and 
layperson medical education [54,55], and one agent was designed to help monitor users’ speech 
[56]. The percentages do not add up to a hundred because some of the studies that addressed 
mental health also fit in one of the other categories. 
 
Figure 3. The number of studies examining conversational agents designed for certain healthcare 
areas or functions (n = 31, some studies counted in two categories) 
The study designs also varied widely, with 29% (9/31) using cross-sectional designs, 
26% (8/31) using randomized controlled trials, 23% (7/21) using qualitative methods, 19% 
(6/31) using cohort studies, and one using a cluster crossover design. The full data extraction 
table is available in Multimedia Appendix D.  
Overall Evaluation of Conversational Agents 
 Overall, about three quarters of studies (22/30) reported positive or mixed results for the 
majority of outcomes. Eight of the studies were coded as reporting positive or mixed evidence 
for 10 or more of the 11 outcomes specified in the SF/HIT; analysis for this review was limited 
to interpretation of impact as reported by study authors to reflect evaluation outcomes. Excluding 
one study, which was an acceptability study only and did not assess the other outcomes, the 
average number of outcomes that were coded as ‘positive or mixed’ was 7 (67%, SD = 2.5). 
However, the number of outcomes met per study ranged from 1-11 (9-100%). Perceived ease of 
use / usefulness (27/30, 90%), process of service delivery / performance (26/30, 87%), 
appropriateness (24/30, 80%), and satisfaction (26/31, 84%) were the outcomes that had the most 
support from the studies. Just over three quarters (23/30) of the studies also reported positive or 
mixed evidence of effectiveness.  
However, very few studies discussed cost effectiveness (5/30, 17% coded as ‘positive or 
mixed’) or the safety, privacy, and security (14/30, 47% coded as ‘positive or mixed’) outcomes 
for the agents being evaluated. Just over a quarter of studies (8/30) had neither positive nor 
mixed reported evidence for more than half of the SF/HIT outcomes. The evaluation of the 
SF/HIT outcomes is summarized in Table 2. 
 


































action N (%) 
Adams [9] 1 1 1 1 1 1 1 1 0 1 1 10 (91) 
Bibault 
[46] 1 1 1 1 1 1 1 1 0 1 1 10 (91) 
Borja- 
Harta [50] 0 1 1 1 1 1 1 0 0 1 0 7 (64) 
Cameron 
[32] 
0 0 1 1 0 1 0 1 0 0 1 5 (45) 
Chaix [45] 1 0 1 1 1 1 1 0 0 1 1 8 (73) 
Chang [8] 0 1 0 1 1 0 1 1 0 1 1 7 (64) 
Crutzen 
[54] 
0 1 1 1 1 1 1 1 0 1 1 9 (82) 
Dimeff [42] 1 0 1 1 1 1 1 1 1 1 1 10 (91) 
Elmasri 
[33] 0 0 0 1 0 1 1 0 0 1 1 5 (45) 
Fitzpatrick 
[13] 1 1 1 1 1 1 1 1 0 1 1 10 (91) 
Friederichs 
[53]  0 0 0 1 0 1 0 1 0 0 1 4 (36) 
Fulmer [34]  1 1 0 0 1 1 1 0 0 0 1 6 (55) 
Galescu 
[52] 0 0 1 1 0 1 0 0 0 0 0 3 (27) 
Ghosh [44] 1 1 1 1 1 1 0 1 0 1 1 9 (82) 
Havik [14] 1 1 1 1 1 1 0 1 1 1 1 10 (91) 
Heyworth 
[47] 0 1 1 1 1 1 1 1 0 1 0 8 (73) 
Hudlicka 
[35] 1 1 1 1 1 1 1 1 1 1 1 11 (100) 
Inkster [36] 1 1 1 1 1 1 0 1 0 1 1 9 (82) 





1 1 1 1 1 1 0 1 1 1 1 10 (91) 
Ly [37] 0 1 0 1 0 1 0 0 0 1 1 5 (45) 
Nakagawa 
[12] 1 0 1 1 1 1 0 0 0 1 1 7 (64) 
Philip 
(2014) [51] 1 1 1 1 1 1 1 1 0 1 1 10 (91) 
Philip 
(2017) [38] 1 1 1 1 1 1 0 1 0 1 1 9 (82) 
Rhee [48] 1 1 1 1 1 1 0 1 0 1 1 9 (82) 
Simon [49] 0 1 0 1 0 1 1 1 0 1 1 7 (64) 
Spänig [43] 0 0 1 0 1 1 0 1 0 1 1 6 (55) 
Washburn 
[41] 
1 0 0 1 1 1 0 0 1 0 0 5 (45) 
Wong [55]  0 0 0 1 0 0 0 0 0 0 0 1 (9) 
Xu [40] 1 0 1 0 1 0 0 0 0 1 1 5 (45) 
Yasavur 
[39]  
0 1 1 1 1  
0 
0 1 0 1 1 7 (64) 
N (%) 17 (57) 19 (63) 
22 
(73) 27 (90) 
23 
(77) 26 (87) 14 (47) 20 (67) 5 (17) 24 (80) 
26 
(84)  
*The impact ‘positive or mixed’ has been coded as 1 and the outcome ‘neutral or negative’ as 0  
 When grouped by the agent’s healthcare scope, studies of certain types of agents appear 
to do better than others (see Table 3). Studies examining screening or diagnosis agents and 
treatment support agents had the highest average number of positive or mixed outcomes (mean = 
10, SD = 0.6 and mean = 9, SD = 1.2, respectively). Treatment support agents had primary 
functions that included empowering patients to engage more fully in clinical appointments, 
encouraging attending screenings for healthcare conditions, and supporting patient self-
management. In contrast, mental health agents focused on addressing challenges related to 
depression, anxiety, and alcohol abuse, among others. However, given the small number of 
studies for each category of agent, this should be interpreted with caution.  
Table 3. Summary of evaluation outcomes by the area of healthcare addressed by the 
conversational agent  
12 
Agent focus  Number 
of studies  
Average number of 
outcomes coded ‘positive 





Mental health [13,32–42] 12 7 (66) 5-11 2.4 
Clinical decision / triage 
support [8,12,40,42–44]  
6 7 (67) 5-10 1.9 
Treatment support [9,45–
49] 
6 9 (79) 7-10 1.2 
Healthcare training 
(students) [15,41,50] 
3 7 (67) 5-10 2.5 
Screening / diagnosis 
[14,38,51] 
3 10 (88) 9-10 0.6 
Healthcare education 
(laypeople) [54,55] 
2 5 (45) 1-9 5.7 
Physical health [52,53] 2 4 (32) 3-4 0.7 
*The number of studies does not add up to 31 because some studies fit into two categories, and the study 
on monitoring speech was not included because it only addressed one of the eleven outcomes. The 
percentages associated with the average number of outcomes varies slightly due to rounding.  
Qualitative User Perceptions  
 18 of the 31 studies included more specific user feedback. The most frequently raised 
issue with the conversational agents (in 9 studies) was poor understanding due to limited 
vocabulary, voice recognition accuracy, or error management of word inputs [13,32–37,41,52]. 
Related to this issue, as the conversational agents often had to ask questions more than once to be 
able to process the response, users in three studies noted disliking that conversations with the 
agents were repetitive [13,36,37]. These are both key areas of improvement for future research 
and development of conversational agents because they represent limitations in the usability of 
the agents in a real-world context. 
Feedback from users in five studies expressed a preference for interactivity, with users in 
one study noting that they liked the interactivity of the chatbot [35,37], and users in the other 
four studies expressing a desire for greater interactivity or relational skills in the conversational 
agent [14,32,34,53]. Similarly, users in four studies reported liking that the agent had a 
personality and/or showed empathy [13,32,34,42] while users in other studies reported disliking 
the lack of personal connection or difficulty empathizing with the agent [35,37,50] or its limited 
conversation and responses [35,56].  
Due to the wide variety of conversational agents, and their aims and healthcare contexts, 
much of the qualitative user perception data concerned distinct aspects of the agents. However, 
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several studies reported feedback concerned with customisation or availability of feature options 
- with two studies commenting on it positively (e.g. having both voice and touch modes to allow 
hands-free work and rapid data input on a triage system for nurses) [8,35], and three studies 
desiring more features and more control [33,37,48]. Additionally, users in two studies suggested 
that better integration of the agent with EHR systems (for a virtual doctor [42]) or healthcare 
providers (for an asthma self-management chatbot [48]) would be useful.  
Other features of the agents that users reported liking were reminders and the assistance 
in forming routines [37,48], that they provided accountability [13,34,48], that they facilitated 
learning [13,34,37], and that they were easy to learn and use [8,15]. Three of the conversational 
agents in the included studies were virtual patients, and users in all three studies reported liking 
that it provided a platform for risk-free learning, because they were not practicing on real 
patients [15,41,50].  
Several of the studies reported user feedback that was specific to that conversational 
agent. This included a preference for telephone IVR over web-based pediatric care guidance [9] 
and for a simple avatar with a computer-generated voice over a more life-like agent with a 
recorded voice [42]. Users in one study reported liking that the agent initiated conversations [37] 
but there was opposite feedback in two studies about the format of response, with users 
preferring pre-formatted options for one chatbot [36] while some users preferred the free-text 
responses for a diagnostic chatbot because it allowed them to provide contextual information but 
others found that it more difficult to know how to respond so the agent would understand [14].  
Other agent-specific negative feedback included that the virtual doctor did not have 
capability to go deep enough or provide access to other materials [42], that too much information 
was provided [13,33] or the interaction was too long [13], the use of non-verbal expressions on 
the avatar [35], and a lack of clarity regarding the aim of the chatbot [37]. Some students who 
used the virtual patients also reported that it was difficult to empathize [50] and that the agent did 
not sufficiently encompass real situational complexity [15]. The variety of specific feedback 
reported demonstrates the importance of examining usability for individual conversational agents 
and tailoring the design to the intended population. While there were some preferences and 
complaints that were frequently reported, much of the feedback was agent-dependent. A 
summary of the thematic analysis is included in Multimedia Appendix E. 
Implications for healthcare provision and resources 
Unfortunately, only a few of the studies discussed any improvement in healthcare 
provision or implications for resources. Two of the studies that suggested improvement in 
healthcare provision were evaluating virtual patients [41,50], and students reported (in one study, 
significantly) increased confidence in their clinical skills and ability to interview patients. Over 
80% of users also reported that the agents helped them follow their treatment more effectively 
[45] and be more prepared for pediatric visits [9]. In a study of an embodied conversational agent 
(ECA) for sleep disorder screening, 65% of users reported thinking that the agent could provide 
significant assistance to physicians [51]. As for resource implications, the study of a preparatory 
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IVR phone call before pediatric visits found that visit time was significantly reduced in the IVR 
group compared to the control [9]. The use of an ECA to screen for depression [38] and a virtual 
doctor for suicidal patients in emergency departments (ED) [42] were suggested by the authors to 
have the potential to save physicians time and reduce the costs associated with ED visits for 
suicidal ideation, but these outcomes were not evaluated. Likewise, another study suggested that 
mindfulness meditation could be of more use with more cost-effective training made available 
via a virtual coach [35]. 
Suggestions such as this - that the conversational agents have the potential to improve 
healthcare provision, save healthcare providers’ time, and reduce costs - were frequent among 
the studies. However, as demonstrated above, very few studies quantified these claims, and even 
fewer measured these outcomes with objective measures. This is a limitation of the studies as a 
whole - even though many were in early stages of testing, claims about potential value to the 
healthcare system in terms of time or money should be substantiated. However, as evidenced by 
the number of ‘neutral or negative’ codings on the evaluation, many of the studies were not 
considering whole system implementation outcomes. It will be important for future development 
of conversational agents to consider outcomes like these from the beginning, so that agents can 
be built that are not only acceptable and usable, but also provide value to the healthcare system.  
Risk of Bias and Quality Assessments 
 There were a variety of study types included in this review, so several different quality 
assessment tools were used to assess the risk of bias in and quality of the 31 included studies. Six 
of the studies could not be classified as RCTs, cohort, qualitative, or cross-sectional studies, and 
their study design was coded as ‘other’ [12,39,40,44,52,55]. Most of these were papers 
describing the development and initial evaluation of conversational agents, and half of them did 
not use participants [40,44,55]. Initially, studies that did not have an explicit design were 
classified as qualitative / interpretative studies. However, upon further analysis, many of the 
studies did not fit the criteria of qualitative studies as evaluating subjective, thematic, non-
numerical data because they evaluated performance metrics such as word error rates [52], 
accuracy [12,39,40,52,55], precision [44], and user experience quantified on Likert scales [39]. 
Therefore, these studies were coded as ‘other’ and assessed using the AXIS tool for cross-
sectional studies, which was deemed to provide the most systematic evaluation of the various 
elements of the studies [30]. The quality of these studies was assessed as best as possible, 
however, the judgments should be considered in the context of these limitations.  
Overall, the quality was poor to moderate. On average, the randomized controlled trials 
(RCTs) [9,13,34,37,46,47,49,53] and qualitative studies [41,48,56] evaluated were generally 
determined to have the highest quality and lowest risk of bias, with none of the other three study 
types meeting more than half of the criteria for the quality assessment. The evaluation of risk of 
bias for the eight RCTs was conducted using the Cochrane Collaboration Risk of Bias tool [28], 
and the results were summarized using the RevMan 5.3 software [57]. Overall, the RCTs 
performed fairly well in the risk of bias assessment. About half of the studies were assessed as 
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having a low risk of selection bias because of proper random sequence generation (5/8) and 
allocation concealment (4/8), and a low risk of reporting bias (4/8), as outcomes reported could 
be compared to a priori protocols or trial registrations. Most studies reported blinding of 
outcome assessors (7/8) and a low risk of attrition bias because of low or equal dropout across 
groups or the use of intention-to-treat analyses (6/8). The majority of studies (5/8) had a high risk 
of performance bias, but this was predominantly because blinding was not possible given the 
intervention.  
 
Figure 4. Risk of bias summary: review authors' judgements about each risk of bias item for each 
included study 
 
Figure 5. Risk of bias graph: review authors' judgements about each risk of bias item presented 
as percentages across all included studies 
 
 The cohort (n = 9) and qualitative (n = 3) studies assessed using the Critical Appraisal 
Skills Programme checklists met on average 5/12 (range: 1-10) and 7/10 (range: 4-9) criteria, 
respectively [29]. Of the cohort studies, the questions with the best performance were “Did the 
study address a clearly focused issue?” (8/9 yes), “Was the follow up long enough?” (8/9 yes), 
and “Do the results of this study fit with other available evidence?” (6/9 yes). Studies performed 
the worst - either through failing to meet the criteria or failing to report it - on questions about 
cohort recruitment (1/9 yes), identifying and accounting for confounding factors (1/9 yes), 
accurate exposure and outcome measurement (2/9 and 3/9 yes, respectively), and the 
applicability of results to the local population (3/9 yes). The qualitative studies, on the other 
hand, performed best on the questions about whether a qualitative methodology was appropriate, 
the consideration of ethical issues, clear statements of findings, and if the results will help locally 
(3/3 yes for each). None of the three studies reported any consideration of the relationship 
between researcher and participant, and also performed poorly on questions about sample 
recruitment, data collection, and data analysis (1/3 yes for each). 
The cross-sectional (n = 5) and ‘other’ (n = 6) studies assessed using the AXIS tool met 
on average 50% (range: 26-80%) and 42% (range: 29-70%) of the criteria, respectively [30]. 
Percentages are reported instead of the exact number of criteria because several of the questions 
were not applicable to the studies, so the total number of criteria assessed per study was not the 
same (averages: 19 and 16, ranges: 18-20 and 10-19, respectively). Overall, the cross-sectional 
studies performed best on questions about the clarity of aims (5/5 yes), appropriate outcome 
variables for the aims (5/5 yes), internal consistency (5/5 yes), and adequate description of basic 
data (4/5 yes). They performed worst on questions about sample selection - if it was taken from 
an appropriate base to represent the population (1/5 yes) and whether the process was likely to 
select a representative sample (0/5 yes) - the use of appropriate outcome measures (previously 
assessed; 0/5 yes), whether the methods were adequately described for replication (1/5 yes), and 
conflicts of interest (1/5 no, most did not report).  
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The ‘other’ studies performed best on the questions about whether the study design was 
appropriate for the aims and if the conclusions were justified by the results (6/6 yes for both), 
and also did well overall on appropriate choice of outcome variables and internal consistency 
(5/6 yes for both). However, all the ‘other’ studies, for whom the questions were applicable, 
performed poorly on questions about the justification of sample size (0/5 yes), whether the 
selection process was likely to get a representative sample (0/5 yes), addressing non-responders 
(0/2 yes), adequate description of basic data (0/4 yes), concerns about non-response bias (0/3 
yes), the presentation of results for all the analyses described in the methods (0/6 yes, although 
this was mostly because analyses were not adequately described in the methods), and conflicts of 
interest (0/6 yes, again because nothing was reported). Furthermore, only one study adequately 
addressed the questions about the use of previously assessed outcome measures (1/5 yes), 
sufficient description of the methods for replication (1/6 yes), and discussion of study limitations 
(1/6 yes). It should be noted that the AXIS tool used to assess the ‘other’ studies was designed 
for cross-sectional studies, and does not fit exactly with the designs of these studies. Therefore, it 
is possible these studies would perform better when assessed by a tool specific to their study 
type. Tables depicting the judgments for each question of the CASP cohort and qualitative 
checklists and the AXIS tool for the cross-sectional and ‘other’ studies are included in 
Multimedia Appendices F-I.  
Discussion 
Principal Findings  
 In this systematic review, we examined 31 studies that evaluated the effectiveness and 
usability of conversational agents in healthcare. Overall, studies reported a moderate amount of 
evidence supporting the effectiveness, usability, and positive user perceptions of the agents. On 
average, two thirds of the studies (67%) reported positive or mixed evidence for each evaluation 
outcome. However, this ranged significantly, with usability, agent performance, and satisfaction 
having the most support across the studies, and cost-effectiveness receiving hardly any. It should 
also be noted that the definitions of ‘effectiveness’ were highly varied and, as evidenced by the 
methodological limitations identified in the quality assessment, rarely evaluated with the scrutiny 
expected for medical devices. While this is promising for the use of conversational agents in 
healthcare, there are a number of limitations in both the studies analysed and the structure of this 
review that question the validity of this finding. 
With regard to qualitative user perceptions of the agents, specific feedback was very 
mixed. Users highlighted many positive factors of the agents, particularly its personality and 
ability to provide empathy and emotional support, that it supports learning, that it’s easy to use 
and access, and that it helps them be accountable, all of which support the generally positive 
evaluations of usability and satisfaction outcomes. However, there were a number of limitations 
of the agents that were consistently raised across the studies that reported qualitative feedback. 
These included that the agents had difficulty understanding them, that they were repetitive and 
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not sufficiently interactive, and that the users had difficulty forming personal connections with 
the agents. This suggests that despite the generally positive usability reported by the studies, 
there are a number of barriers to successful use of conversational agents in healthcare that will 
need to be addressed before they can achieve the greatest impact. It should be noted that this 
review only included studies of conversational agents that NLP, and that free-text inputs are 
likely to present greater difficulties for comprehension.  
The results of this systematic review are largely consistent with the literature, particularly 
the previous systematic review evaluating conversational agents in healthcare [2]. They also 
found a limited quality of design and evidence in the included studies, with inconsistent 
reporting of study methods (including methods of selection, attrition, and a lack of validated 
outcome measures) and conflicts of interest [2]. They identified that high-quality evidence of 
effectiveness and patient safety was limited, which was also observed in this review. Likewise, 
they noted that high overall satisfaction was generally reported by the studies but that the most 
common issues with the conversational agents related to language understanding or poor 
dialogue management, which is consistent with our findings [2]. Some of this similarity in results 
is likely due to the overlap in included studies - 7 of their 17 studies were also included in our 
review [2].  
Quality of the Evidence 
 As noted in the previous systematic review [2], there were significant issues with the 
quality of many of the included studies. One of the consistent issues among many of them was 
the risk of selection bias. A large proportion of the studies relied on volunteers for the study, 
many of whom were recruited via self-selection means such as flyers and emails or downloading 
the app being studied. The risk with self-selection recruitment is that participants who elect to 
take part in the study are already more positively predisposed to new technologies than those 
who don’t participate, which would tend to weight the evaluation of the technology more 
positively. To make matters worse, several of the studies also did not sufficiently report their 
recruitment strategies, so their potential selection bias cannot be accurately evaluated. In research 
such as this, where user perceptions are a main outcome, this is a serious concern. Future studies 
should take care to implement recruitment strategies that minimize the risk of this selection bias 
or balance the potential bias in evaluations by actively recruiting participants who are less 
inclined towards new technology.  
 Another limitation of many of the studies is small sample sizes. Almost two thirds of the 
studies (19/31) used samples of less than 100 participants or items of analysis (voice clips, 
clinical scenarios) with a median sample size of 48 across all the studies. Many also did not 
sufficiently report demographic data or whether their sample was representative of their target 
population. While many of these studies were early feasibility and usability trials, this is an 
important issue to address in future research testing these agents, to determine whether an agent 
will be used - and used effectively - by its target population. 
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Limitations  
 The validity of the evidence extracted from the included studies was also affected by 
limitations in the structure of the review. The Synthesis Framework for the Assessment of Health 
Information Technology (SF/HIT) was used to provide a structured set of whole system 
implementation outcomes on which to evaluate the conversational agents [31]. However, an 
issue with the use of this framework that was discovered during analysis was that many of the 
included studies were describing system innovation. Therefore, they did not address or provide 
evidence for many of the outcomes described by the SF/HIT. Additionally, as the included data 
indicated self-reported impact in the studies of effectiveness, the study effectiveness is biased 
favorably to authors reporting of impact.  
This limitation in the use of the framework for this review also highlights a limitation in 
many of these studies; namely, that they are not thinking about whole system implementation 
from the early stages of agent design, development, and testing. It is possible that lack of 
evaluation about the implications of the agents for healthcare provision and resources was due to 
an emphasis on technology development and evaluation, rather than system integration. This is a 
pervasive issue in technological innovation; so much so that it drove the development of the non-
adoption, abandonment, scale-up, spread, and sustainability (NASSS) framework as a means of 
predicting and assessing the success of new health technologies [58] the development and 
evaluation of new conversational agents, to ensure that these later-stage implications of 
healthcare provision, cost-effectiveness, and privacy and security are being sufficiently 
considered from the early stages of innovation. They must also be properly evaluated with a 
large sample of users, rather than simply presented as unsubstantiated claims that the agent will 
reduce costs and save healthcare providers time.  
Additionally, in accordance with their framework, the outcomes’ impact on each outcome 
was coded as ‘positive or mixed’ or ‘neutral or negative’. However, this combination of positive 
and mixed outcomes reduces the granularity of the results. During the coding process, several 
outcomes were distinctly coded as ‘positive’ or as ‘mixed’, and collating the two outcome 
impacts into one reduces the precision of the information presented to the readers. Additionally, 
studies that did not assess the outcome in question were coded as ‘neutral or negative’ because 
they did provide explicit support for the outcome. In the analysis, outcomes were initially coded 
separately as positive, mixed, positive or mixed (for studies that reported a positive outcome but 
did not provide sufficient statistical evidence), and neutral or negative. This table is available in 
Multimedia Appendix J. Positive and mixed outcomes were combined for the final presentation 
of the data in line with the framework. However, it might be more useful to distinguish between 
studies that attempted to find significant evidence for an outcome but did not, and those that did 
not attempt it. This would provide a clearer picture of which outcomes are not being supported 
by the evidence and should be targeted for improvement, and which outcomes still need to be 
examined. In future, it would be worth evaluating whether the coding system should be adjusted 
to provide a more detailed and informative summary of the evidence.  
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Further limitations of this review are that we limited the focus to include only 
unconstrained natural language processing and interaction. This was chosen as a focus because 
of the advantages NLP poses for simulating human-to-human interaction, however, it will have 
necessarily excluded studies of relevant conversational agents that could be satisfactory, useful, 
and effective in addressing current healthcare challenges. Additionally, no spidering searches 
were used to identify potentially relevant studies in the references of the included studies that 
were missed in the initial search. The exclusion of conference abstracts might also have missed 
relevant papers that were classed as abstracts; however, a previous systematic review that 
included conference abstracts in their search only had one included in their final selection [2]. 
The inclusion of only studies published in English also likely excluded relevant research on 
conversational agents conducted in other countries. These limitations should be corrected in 
future studies in order to ensure that the full body of relevant literature is examined.   
Future Directions  
 Future reviews of conversational agents in healthcare could be extended to include 
constrained NLP and non-NLP conversational agents.  A synthesis of the evidence identified 
here with other types of conversational agent in healthcare - perhaps structured according to the 
taxonomy suggested by Montenegro et al. [5] - could be used to examine overall trends, and 
provide a better picture of what is being used, what works, and what doesn’t, to further guide the 
development of the conversational agents that are most likely to be successful.  
 Future research should also include more qualitative evaluations of the features that users 
like and dislike. Only just over half (18/31) of the studies included in this review reported 
specific user feedback, despite the fact that 7 of the remaining 13 studies conducted some 
measure of usability or user perceptions. It will be important to identify all of the structural, 
physical, and psychological barriers to use if conversational agents are to achieve their potential 
for improving healthcare provision and reducing the strain on healthcare resources. To this aim, 
it would be useful for future studies to structure their evaluation of conversational agents around 
a behavioural change framework (for example, the Behaviour Change Wheel framework [59]). 
This is important not just when evaluating the effectiveness of behaviour change focused 
conversational agents, but when determining whether and how the adoption of new 
conversational agent technology will be successful.  
 It will be important for future studies of conversational agents to take care to properly 
structure and report their studies to improve the quality of the evidence. Without high-quality 
evidence, it is difficult to assess the current state of conversational agents in healthcare, what is 
working, and what needs to be improved to make them a more useful tool. Likewise, there is a 
gap in the evidence regarding the health economics of these agents. Very few studies in this 
review even discussed the cost analysis of the agent in questions, let alone providing substantive 
evidence about its cost-effectiveness. The evaluation of costs and outcomes of new technologies, 
as well as their privacy, security, and interoperability, will be necessary to advance value-based 
healthcare [60]. However, there was very little evidence to suggest that the conversational agents 
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examined in this review considered or addressed these concerns. User feedback on two of the 
studies even noted that better interoperability between the agent and EHRs or healthcare 
providers would improve its usefulness.  
Conclusions 
 The objective of this systematic review was to provide a synthesis of the evidence of 
conversational agents’ usability, effectiveness, and satisfactoriness in healthcare. Although the 
studies generally reported positive outcomes relating to the agents’ usability and effectiveness, 
the quality of the evidence was not sufficient to provide strong evidence to support these claims. 
This study extended the literature by expanding the summary of the literature to examine a whole 
system set of evaluation outcomes - including cost-effectiveness and privacy and security, which 
have not been systematically examined in previous reviews. Additionally, it provides a distinct 
contribution by conducting a thematic analysis of qualitative user perceptions of the agents. 
Further research is needed to examine the cost-effectiveness and value of these agents in 
healthcare - both in their current and potential states. Higher quality studies - with more 
consistent reporting of design methods and better sample selection - are also needed to more 
accurately assess the usefulness of, and identify the key areas of improvement for, current 
conversational agents. A more holistic approach to the design, development, and evaluation of 
conversational agents will help drive innovation and improve their value in healthcare.  
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Multimedia Appendix A. Search queries and number of results for each database  
Database Search terms Retrieved  
PubMed ((((Speech recognition software[mh] or "Conversational agent*"[tiab] or "embodied 
conversational agent*"[tiab] or chatbot*[tiab] or avatar*[tiab] or "dialog* system"[tiab] 
or "speech recognition software"[tiab] or "voice recognition software"[tiab] or "virtual 
assistan*"[tiab] or "virtual nurs*"[tiab] or "virtual patient"[tiab] or "virtual 
coach*"[tiab] or "virtual agent"[tiab] or "relation* agent"[tiab] or "assistance 
technol*"[tiab] or "intelligent assistan*"[tiab] or "digital assistan*"[tiab] or "natural 
language interface"[tiab] or "interactive computer agent"[tiab] or "computer-assisted 
instruction"[tiab] or "natural language communication"[tiab] or "natural language 
understanding"[tiab] or "unconstrained natural language processing"[tiab])) AND 
(Health facilities[mh] or Health communication[mh] or Health services[mh] or exp 
health services accessibility[mh] or Delivery of healthcare[mh] or exp Health 
behavior[mh] or Exercise[mh] or Simulation training[mh] or Health education[mh] or 
health literacy[mh] or "patient acceptance of healthcare"[mh] or health knowledge, 
attitudes, practice[mh] or "treatment adherence or compliance"[mh] or asthma[mh] or 
sex education[mh] or exp aged[mh] or exp counseling[mh] or smoking cessation[mh] or 
exp diet[mh] or exp education, medical[mh] or exp substance-related disorders[mh] or 
social skills[mh] or autism spectrum disorder[mh] or patient education as topic[mh] or 
diabetes mellitus[mh] or cardiovascular disease[mh] or pulmonary disease, chronic 
obstructive[mh] or "healthcare delivery"[tiab] or "healthcare access"[tiab] or 
health[tiab] or healthcare[tiab] or behavio?r[tiab] or exerci*[tiab] or diet[tiab] or 
"simulation training"[tiab] or education[tiab] or "elderly care"[tiab] or "sex* 
education"[tiab] or "health literacy"[tiab] or "counsel?ing"[tiab] or "well-being"[tiab] or 
"smoking cessation"[tiab] or "cognitive dysfunction"[tiab] or "mental health"[tiab] or 
"social skills"[tiab] or "autism spectrum disorder"[tiab] or diabetes[tiab] or "heart 
health"[tiab] or "chronic obstructive pulmonary disease"[tiab] or "COPD"[tiab] or "sun 
protection"[tiab] or "physical activity"[tiab]))) AND ("Outcome Assessment (Health 
Care)"[mh] or program evaluation[mh] or feasibility studies[mh] or pilot projects[mh] 
or "diffusion of innovation"[mh] or cost-benefit analysis[mh] or "Reproducibility of 
results"[mh] or Feasib*[tiab] or usab*[tiab] or evaluat*[tiab] or outcome*[tiab] or 
acceptability[tiab] or acceptance[tiab] or "treatment adherence"[tiab] or effectiv*[tiab] 
or adoption[tiab] or assess*[tiab] or "user experience*"[tiab] or efficacy[tiab] or 
utility[tiab] or utili?ation[tiab] or "patient* acceptance"[tiab] or "patient* 
acceptability"[tiab] or "user* acceptance"[tiab] or "user* acceptability"[tiab] or "user* 
perce*"[tiab] or "patient* perce*"[tiab] or "user* perspective*"[tiab] or "patient* 





(Speech recognition software/ or ((Conversational adj1 agent*) or (embodied adj2 
agent*) or chatbot* or avatar* or (dialog* adj1 system) or speech recognition software 
or voice recognition software or (virtual adj1 (assistan* or nurs* or patient or coach* or 
agent)) or (relation* adj1 agent) or assistance technol* or (intelligent adj2 assistan*) or 
(digital adj2 assistan*) or natural language interface or interactive computer agent or 
computer-assisted instruction or natural language communication or natural language 
understanding or unconstrained natural language processing).ti,ab.) AND (Health 
facilities/ or Health communication/ or Health services/ or exp health services 
accessibility/ or Delivery of healthcare/ or exp Health behavior/ or Exercise/ or 
Simulation training/ or Health education/ or health literacy/ or "patient acceptance of 
healthcare"/ or health knowledge, attitudes, practice/ or "treatment adherence or 
compliance"/ or asthma/ or sex education/ or exp aged/ or exp counseling/ or smoking 
cessation/ or exp diet/ or exp education, medical/ or exp substance-related disorders/ or 
social skills/ or autism spectrum disorder/ or patient education as topic/ or diabetes 
mellitus/ or cardiovascular disease/ or pulmonary disease, chronic obstructive/ or 
(healthcare delivery or healthcare access or health or healthcare or behavio?r or exerci* 
or diet or simulation training or education or elderly care or sex* education or health 
literacy or counsel?ing or well-being or smoking cessation or cognitive dysfunction or 
mental health or social skills or autism spectrum disorder or diabetes or heart health or 
chronic obstructive pulmonary disease or COPD or sun protection or physical 
activity).ti,ab.) AND ("Outcome Assessment (Health Care)"/ or program evaluation/ or 
feasibility studies/ or pilot projects/ or "diffusion of innovation"/ or cost-benefit 
analysis/ or "Reproducibility of results"/ or (Feasib* or usab* or evaluat* or outcome* 
or acceptability or acceptance or treatment adherence or effectiv* or adoption or assess* 
or user experience* or efficacy or utility or utili?ation or patient* acceptance or patient* 
acceptability or user* acceptance or user* acceptability or user* perce* or patient* 






(Automatic speech recognition/ or ((Conversational adj1 agent*) or (embodied adj2 
agent*) or chatbot* or avatar* or (dialog* adj1 system) or (dialog* adj1 agent) or 
speech recognition software or voice recognition software or (virtual adj1 (assistan* or 
nurs* or patient or coach* or agent)) or (relation* adj1 agent) or assistance technol* or 
(intelligent adj2 assistan*) or (digital adj2 assistan*) or natural language interaction or 
interactive computer agent or computer-assisted instruction or natural language 
communication or natural language understanding or unconstrained natural language 
processing).ti,ab.) AND (Health care facility/ or medical information/ or Health service/ 
or exp healthcare access/ or healthcare delivery/ or exp Health behavior/ or Exercise/ or 
Simulation training/ or Health education/ or health literacy/ or patient attitude/ or 
attitude to health/ or patient compliance/ or asthma/ or sexual education/ or exp aged/ or 
exp counseling/ or smoking cessation/ or exp diet/ or exp medical education/ or exp 
drug dependence/ or social competence/ or autism/ or patient education/ or diabetes 
mellitus/ or cardiovascular disease/ or chronic obstructive lung disease/ or (healthcare 
delivery or healthcare access or health or healthcare or behavio?r or exerci* or diet or 
simulation training or education or elderly care or sex* education or health literacy or 
counsel?ing or well-being or smoking cessation or cognitive dysfunction or mental 
health or social skills or autism spectrum disorder or diabetes or heart health or chronic 
obstructive pulmonary disease or COPD or sun protection or physical activity).ti,ab.) 
AND (Outcome assessment/ or program evaluation/ or feasibility study/ or pilot study/ 
or mass communication/ or cost benefit analysis/ or reproducibility/ or (feasib* or usab* 
or evaluat* or outcome* or acceptability or acceptance or treatment adherence or 
effectiv* or adoption or assess* or user experience* or efficacy or utility or utili?ation 
or patient* acceptance or patient* acceptability or user* acceptance or user* 
acceptability or user* perce* or patient* perce* or user* perspective* or patient* 
perspective* or user* view* or patient* view* or cost*).ti,ab.) 
2145 
29 
CINAHL  ((MH Voice recognition systems) OR TI ((Conversational n1 agent*) or (embodied n2 
agent*) or chatbot* or avatar* or (dialog* n1 system) or speech recognition software or 
voice recognition software or (virtual n1 (assistan* or nurs* or patient or coach* or 
agent)) or (relation* n1 agent) or assistance technol* or (intelligent n2 assistan*) or 
(digital n2 assistan*) or natural language interface or interactive computer agent or 
computer-assisted instruction or natural language communication or natural language 
understanding or unconstrained natural language processing) OR AB ((Conversational 
n1 agent*) or (embodied n2 agent*) or chatbot* or avatar* or (dialog* n1 system) or 
speech recognition software or voice recognition software or (virtual n1 (assistan* or 
nurs* or patient or coach* or agent)) or (relation* n1 agent) or assistance technol* or 
(intelligent n2 assistan*) or (digital n2 assistan*) or natural language interface or 
interactive computer agent or computer-assisted instruction or natural language 
communication or natural language understanding or unconstrained natural language 
processing)) AND ((MH “Health facilities”) or (MH “Communication”) or (MH “health 
services accessibility+”) or (MH “Health behavior”) or (MH “exercise”) or (MH 
“Computerized clinical simulation testing) or (MH “health education”) or (MH “health 
literacy”) or (MH “Patient attitudes”) or (MH “Attitude to health”) or (MH “patient 
compliance”) or (MH “asthma”) or (MH “sex education”) or (MH “Aged+”) or (MH 
“Counseling+”) or (MH “smoking cessation”) or (MH “diet+”) or (MH “Education, 
medical+”) or (MH “substance dependence+) or (MH “social skills training”) or (MH 
“Autistic disorder”) or (MH “patient education”) or (MH "diabetes mellitus") or (MH 
"cardiovascular diseases") or (MH "Pulmonary Disease, Chronic Obstructive") OR TI 
(healthcare delivery or healthcare access or health or healthcare or behavio?r or exerci* 
or diet or simulation training or education or elderly care or sex* education or health 
literacy or counsel?ing or well-being or smoking cessation or cognitive dysfunction or 
mental health or social skills or autism spectrum disorder or diabetes or heart health or 
chronic obstructive pulmonary disease or COPD or sun protection or physical activity) 
OR AB (healthcare delivery or healthcare access or health or healthcare or behavio?r or 
exerci* or diet or simulation training or education or elderly care or sex* education or 
health literacy or counsel?ing or well-being or smoking cessation or cognitive 
dysfunction or mental health or social skills or autism spectrum disorder or diabetes or 
heart health or chronic obstructive pulmonary disease or COPD or sun protection or 
physical activity)) AND ((MH “Outcome assessment”) or (MH “Program evaluation”) 
or (MH “pilot studies”) or (MH “Diffusion of innovation”) or (MH “Cost benefit 
anaylsis”) or (MH “reproducibility of results”) OR TI (feasib* or usab* or evaluat* or 
outcome* or acceptability or acceptance or treatment adherence or effectiv* or adoption 
or assess* or user experience* or efficacy or utility or utili?ation or patient* acceptance 
or patient* acceptability or user* acceptance or user* acceptability or user* perce* or 
patient* perce* or user* perspective* or patient* perspective* or user* view* or 
patient* view* or cost*) OR AB (feasib* or usab* or evaluat* or outcome* or 
acceptability or acceptance or treatment adherence or effectiv* or adoption or assess* or 
user experience* or efficacy or utility or utili?ation or patient* acceptance or patient* 
acceptability or user* acceptance or user* acceptability or user* perce* or patient* 






((MH Voice recognition systems) OR TI ((Conversational n1 agent*) or (embodied n2 
agent*) or chatbot* or avatar* or (dialog* n1 system) or speech recognition software or 
voice recognition software or (virtual n1 (assistan* or nurs* or patient or coach* or 
agent)) or (relation* n1 agent) or assistance technol* or (intelligent n2 assistan*) or 
(digital n2 assistan*) or natural language interface or interactive computer agent or 
computer-assisted instruction or natural language communication or natural language 
understanding or unconstrained natural language processing) OR AB ((Conversational 
n1 agent*) or (embodied n2 agent*) or chatbot* or avatar* or (dialog* n1 system) or 
speech recognition software or voice recognition software or (virtual n1 (assistan* or 
nurs* or patient or coach* or agent)) or (relation* n1 agent) or assistance technol* or 
(intelligent n2 assistan*) or (digital n2 assistan*) or natural language interface or 
interactive computer agent or computer-assisted instruction or natural language 
communication or natural language understanding or unconstrained natural language 
processing)) AND ((MH “Health facilities”) or (MH “Communication”) or (MH “health 
services accessibility+”) or (MH “Health behavior”) or (MH “exercise”) or (MH 
“Computerized clinical simulation testing) or (MH “health education”) or (MH “health 
literacy”) or (MH “Patient attitudes”) or (MH “Attitude to health”) or (MH “patient 
compliance”) or (MH “asthma”) or (MH “sex education”) or (MH “Aged+”) or (MH 
“Counseling+”) or (MH “smoking cessation”) or (MH “diet+”) or (MH “Education, 
medical+”) or (MH “substance dependence+) or (MH “social skills training”) or (MH 
“Autistic disorder”) or (MH “patient education”) or (MH "diabetes mellitus") or (MH 
"cardiovascular diseases") or (MH "Pulmonary Disease, Chronic Obstructive") OR TI 
(healthcare delivery or healthcare access or health or healthcare or behavio?r or exerci* 
or diet or simulation training or education or elderly care or sex* education or health 
literacy or counsel?ing or well-being or smoking cessation or cognitive dysfunction or 
mental health or social skills or autism spectrum disorder or diabetes or heart health or 
chronic obstructive pulmonary disease or COPD or sun protection or physical activity) 
OR AB (healthcare delivery or healthcare access or health or healthcare or behavio?r or 
exerci* or diet or simulation training or education or elderly care or sex* education or 
health literacy or counsel?ing or well-being or smoking cessation or cognitive 
dysfunction or mental health or social skills or autism spectrum disorder or diabetes or 
heart health or chronic obstructive pulmonary disease or COPD or sun protection or 
physical activity)) AND ((MH “Outcome assessment”) or (MH “Program evaluation”) 
or (MH “pilot studies”) or (MH “Diffusion of innovation”) or (MH “Cost benefit 
anaylsis”) or (MH “reproducibility of results”) OR TI (feasib* or usab* or evaluat* or 
outcome* or acceptability or acceptance or treatment adherence or effectiv* or adoption 
or assess* or user experience* or efficacy or utility or utili?ation or patient* acceptance 
or patient* acceptability or user* acceptance or user* acceptability or user* perce* or 
patient* perce* or user* perspective* or patient* perspective* or user* view* or 
patient* view* or cost*) OR AB (feasib* or usab* or evaluat* or outcome* or 
acceptability or acceptance or treatment adherence or effectiv* or adoption or assess* or 
user experience* or efficacy or utility or utili?ation or patient* acceptance or patient* 
acceptability or user* acceptance or user* acceptability or user* perce* or patient* 







(recordAbstract:(+Speech +recognition +software) OR recordAbstract:(+conversational 
+agent) OR recordAbstract:(+embodied +agent) OR recordAbstract:(chatbot*) OR 
recordAbstract:(avatar*) OR recordAbstract:(+dialog* +system) OR 
recordAbstract:(+voice +recognition +software) OR recordAbstract:(+virtual 
+assistan*) OR recordAbstract:(+virtual +nurs*) OR recordAbstract:(+virtual +patient) 
OR recordAbstract:(+virtual +coach*) OR recordAbstract:(+virtual +agent) OR 
recordAbstract:(+relation* +agent) OR recordAbstract:(+assistance +technol*) OR 
recordAbstract:(+intelligent +assistan*) OR recordAbstract:(+digital +assistan*) OR 
recordAbstract:(+natural +language +interface) OR recordAbstract:(+interactive 
+computer +agent) OR recordAbstract:(+computer +assisted +instruction) OR 
recordAbstract:(+natural +language +communication) OR recordAbstract:(+natural 
+language +understanding) OR recordAbstract:(+unconstrained +natural +language 
+processing)) AND ((recordAbstract:(+health +facilities) OR recordAbstract:(+health 
+communication) OR recordAbstract:(+health +services) OR recordAbstract:(+health 
+access) OR recordAbstract:(+healthcare +delivery) OR recordAbstract:(+health 
+behavior) OR recordAbstract:(+health +behaviour) OR recordAbstract:(+exerci*) OR 
recordAbstract:(+simulation +training) OR recordAbstract:(+health +education) OR 
recordAbstract:(+health +literacy) OR recordAbstract:(+health +knowledge) OR 
recordAbstract:(+health +practice) OR recordAbstract:(+health +attitudes) OR 
recordAbstract:(+treatment +compliance) OR recordAbstract:(+treatment +adherence) 
OR recordAbstract:(+asthma) OR recordAbstract:(+sex* +education) OR 
recordAbstract:(+elderly +care) OR recordAbstract:(+counseling) OR 
recordAbstract:(+counselling) OR recordAbstract:(+smoking +cessation) OR 
recordAbstract:(+diet) OR recordAbstract:(+medical +education) OR 
recordAbstract:(+substance-related +disorders) OR recordAbstract:(+social +skills) OR 
recordAbstract:(+autism) OR recordAbstract:(+patient +education) OR 
recordAbstract:(+health) OR recordAbstract:(+healthcare) OR 
recordAbstract:(+education) OR recordAbstract:(+health +literacy) OR 
recordAbstract:(+wellbeing) OR recordAbstract:(+cognitive +dysfunction) OR 
recordAbstract:(+mental +health) OR recordAbstract: (diabetes) OR recordAbstract: 
(+cardiovascular +disease) OR recordAbstract: (+sun +protection) OR recordAbstract: 
(+chronic +obstructive +pulmonary +disease) OR recordAbstract: (COPD) OR 
recordAbstract: (+physical +activity)) AND ((recordAbstract:(+outcome*) OR 
recordAbstract:(+program +evaluation) OR recordAbstract:(+feasibility +stud*) OR 
recordAbstract:(+pilot +stud*) OR recordAbstract:(+cost*) OR 
recordAbstract:(+reproducibility) OR recordAbstract:(+feasib*) OR 
recordAbstract:(+usab*) OR recordAbstract:(+evaluat*) OR recordAbstract:(+effectiv*) 
OR recordAbstract:(+adoption) OR recordAbstract:(+assess*) OR 
recordAbstract:(+user +experience*) OR recordAbstract:(+efficacy) OR 
recordAbstract:(+utility) OR recordAbstract:(+utilisation) OR 
recordAbstract:(+utilization) OR recordAbstract:(+patient* +accept*) OR 
recordAbstract:(+user* +accept*) OR recordAbstract:(+user* +perce*) OR 
recordAbstract:(+patient* +perce*) OR recordAbstract:(+user* +perspective) OR 





Multimedia Appendix B 
The retrieval was conducted in a series of searches due to limitation in the number of 
search criteria that could be specified. These were conducted in line with the original search 
categories. The exclusion searches were derived from characteristics of irrelevant studies 
identified. Pass refers to a search following which the subsequent search was conducted on the 
subset of studies retrieved in the previous pass.  
  
First pass: Any field = Conversation* OR chat* OR virtual OR interactive OR relational OR 
speech OR voice OR natural language  
Second pass: Any field = health*  
Third pass: Any field = Outcome OR evaluat* OR effect* OR efficacy OR feasib* OR usab* 
OR accepta* OR perce* 
Fourth pass: Title = NOT (review OR protocol OR guidelines)  
Fifth pass:  Any field = NOT (surgery OR surgical OR ecol* OR animal OR industr* OR 
transcription OR imaging OR librar* OR social media)  
Sixth pass: Year = greater than or equal to 2008    
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Study population N (study arms) Conversational agent  
Adams et al 
(2014) [9] 
RCT USA Children aged 4 
months to 11 years 
who had an RHCM 
or well-child visit 
475 (Personal Health 
Partner: n=293; single 
automated call: n=182) 
Personal Health Partner 
Bibault et al 
(2019) [46] 
RCT France Patients with breast 
cancer and their 
relatives 
142 (Vik: n=71; 
physician: n=71)  
Vik 
Borja-Harta 
et al (2019) 
[50] 
Pre-post USA Pharmacy students  203 Shadow Health 
Cameron et 
al (2019) [32] 
Cross- 
sectional 








France Patients with breast 
cancer and their 
relatives 
958 Vik 
















Adolescents 929 Bzz 






admitted due to acute 
suicidal crisis 






Australia Young adults (18-25) 
at low to medium risk 
of alcoholism 
17 Chatbot to address 
substance abuse 
Fitzpatrick et 
al (2017) [13] 
RCT USA University students 
who self-identified 
with depression and 
anxiety 
70 (Woebot: n = 34, e-
book control: n = 36) 
Woebot 
Friederichs et 
al (2014) [53] 
RCT The 
Netherlands 
Adults (18-70) 958; 500 at follow up 2 
(avatar: n=162; text: 
n=146; control: n=192) 
AVATAR 
Fulmer et al 
(2018) [34] 
RCT USA Students 75 (intervention: n=50 
[group 1: n=24; group 
2: n=26]; control: n=25) 
Tess 
34 




USA Patients with chronic 
heart failure 
14 Computer assistant for 
robust dialogue 
interaction and care 
(CARDIAC) 
Ghosh et al 
(2018) [44]  
Qualitative Australia Clinical scenarios 30 Quro 
Havik et al 
(2019) [14] 
Cohort Norway General population 11 ROB 
Heyworth et 
al (2014) [47] 
RCT United States Women 50-64 with 
risk factors for 
osteoporosis 
4685 (IVR call: n = 
1565, usual care: n = 
1558, usual care + 
mailed info: n = 1562) 
Interactive Voice 




Cohort Not reported Students 32 (coach vs. written 
and audio materials, n 
not stated)  
“Chris” (virtual 
mindfulness coach) 
Inkster et al 
(2018) [36] 
Cohort Global General population 129  Wysa app 
Ireland et al 
(2016) [56] 
Qualitative Australia General population 33 Harlie 
Isaza- 
Restrepo et al 
(2018) [15] 
Pre-post Columbia Undergraduate 
medical students 
20 Virtual Patient 
Ly et al 
(2017) [37] 
RCT Sweden Non-clinical 
population 
28 (chatbot: n = 14, 
wait-list control: n = 14) 
Shim 
Nakagawa et 
al (2018) [12] 
Qualitative Japan General population 14 Telecare system that 
estimates QoL 
Philip et al 
(2014)  [51] 
Cohort France Sleep clinic patients 
and health controls  
62 (patients: n = 32, 








France Sleep clinic patients 
aged 18-65 
179 ECA for diagnosing 
MDD 
Rhee et al 
(2014) [48] 
Qualitative United States Adolescent-parent 
dyads 
15 dyads Mobile phone-based 
asthma self-management 
aid for adolescents 
(mASMAA) 
Simon et al 
(2010) [49]    
RCT United States Men and women 
aged 50 to 64  
20,938 (ATO-SR: n = 
10,432, usual care: n = 
10,506) 
Automated telephone 
outreach with speech 
recognition (ATO-SR) 





Germany University students 320 Virtual doctor 
Washburn et 
al (2016) [41] 
Qualitative United States Medical students  5 Virtual patient software 
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